JP2023180678A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023180678A5 JP2023180678A5 JP2022094192A JP2022094192A JP2023180678A5 JP 2023180678 A5 JP2023180678 A5 JP 2023180678A5 JP 2022094192 A JP2022094192 A JP 2022094192A JP 2022094192 A JP2022094192 A JP 2022094192A JP 2023180678 A5 JP2023180678 A5 JP 2023180678A5
- Authority
- JP
- Japan
- Prior art keywords
- bathing
- water
- bicarbonate
- temperature
- blood flow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000003287 bathing Methods 0.000 claims description 206
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical group OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 160
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 160
- 230000017531 blood circulation Effects 0.000 claims description 89
- 239000003826 tablet Substances 0.000 claims description 68
- 230000036760 body temperature Effects 0.000 claims description 48
- 150000007524 organic acids Chemical class 0.000 claims description 41
- 238000000034 method Methods 0.000 claims description 34
- 239000002202 Polyethylene glycol Substances 0.000 claims description 32
- 229920001223 polyethylene glycol Polymers 0.000 claims description 32
- 238000010521 absorption reaction Methods 0.000 claims description 20
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 16
- 150000008064 anhydrides Chemical class 0.000 claims description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 13
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 12
- 239000007891 compressed tablet Substances 0.000 claims description 12
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 12
- 230000003860 sleep quality Effects 0.000 claims description 11
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 9
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 9
- 239000011736 potassium bicarbonate Substances 0.000 claims description 9
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 9
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 8
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 8
- 239000013040 bath agent Substances 0.000 claims description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 6
- 235000011181 potassium carbonates Nutrition 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 235000005985 organic acids Nutrition 0.000 claims description 5
- 238000007619 statistical method Methods 0.000 claims description 5
- 238000000692 Student's t-test Methods 0.000 claims description 3
- 238000012353 t test Methods 0.000 claims description 3
- URWNQRKGSOTJKI-NTISSMGPSA-N C(CCCCCCCCCCCCC)(=O)CN[C@@H](C)C(=O)O.[Na] Chemical compound C(CCCCCCCCCCCCC)(=O)CN[C@@H](C)C(=O)O.[Na] URWNQRKGSOTJKI-NTISSMGPSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- WLGDAKIJYPIYLR-UHFFFAOYSA-M octane-1-sulfonate Chemical compound CCCCCCCCS([O-])(=O)=O WLGDAKIJYPIYLR-UHFFFAOYSA-M 0.000 claims description 2
- 229940086066 potassium hydrogencarbonate Drugs 0.000 claims description 2
- 108700004121 sarkosyl Proteins 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 claims description 2
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 claims description 2
- DAJSVUQLFFJUSX-UHFFFAOYSA-M sodium;dodecane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCS([O-])(=O)=O DAJSVUQLFFJUSX-UHFFFAOYSA-M 0.000 claims description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 128
- 239000000654 additive Substances 0.000 description 68
- 239000001569 carbon dioxide Substances 0.000 description 64
- 229910002092 carbon dioxide Inorganic materials 0.000 description 64
- 230000000996 additive effect Effects 0.000 description 39
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 38
- 239000007789 gas Substances 0.000 description 37
- 230000001965 increasing effect Effects 0.000 description 29
- 230000000694 effects Effects 0.000 description 27
- 210000004204 blood vessel Anatomy 0.000 description 24
- 238000006386 neutralization reaction Methods 0.000 description 20
- 230000007935 neutral effect Effects 0.000 description 17
- 238000010586 diagram Methods 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 14
- 210000003491 skin Anatomy 0.000 description 14
- 239000008187 granular material Substances 0.000 description 13
- 230000008859 change Effects 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 230000002378 acidificating effect Effects 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 210000002460 smooth muscle Anatomy 0.000 description 7
- 102000008052 Nitric Oxide Synthase Type III Human genes 0.000 description 6
- 108010075520 Nitric Oxide Synthase Type III Proteins 0.000 description 6
- 210000001124 body fluid Anatomy 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 5
- 230000037374 absorbed through the skin Effects 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000000748 compression moulding Methods 0.000 description 5
- 238000005469 granulation Methods 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- -1 CO3-2 ions Chemical class 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 238000013019 agitation Methods 0.000 description 4
- 210000000467 autonomic pathway Anatomy 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 125000004122 cyclic group Chemical group 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 238000005187 foaming Methods 0.000 description 4
- 238000000465 moulding Methods 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 210000003556 vascular endothelial cell Anatomy 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 206010033675 panniculitis Diseases 0.000 description 3
- 210000004003 subcutaneous fat Anatomy 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000002618 waking effect Effects 0.000 description 3
- XKMLYUALXHKNFT-UUOKFMHZSA-N Guanosine-5'-triphosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XKMLYUALXHKNFT-UUOKFMHZSA-N 0.000 description 2
- 108010078321 Guanylate Cyclase Proteins 0.000 description 2
- 102000014469 Guanylate cyclase Human genes 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 210000000476 body water Anatomy 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000004617 sleep duration Effects 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 210000000707 wrist Anatomy 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000011362 coarse particle Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000036757 core body temperature Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 210000003989 endothelium vascular Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000007427 paired t-test Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000000865 phosphorylative effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 238000000551 statistical hypothesis test Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 210000001644 umbilical artery Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022094192A JP2023180678A (ja) | 2022-06-10 | 2022-06-10 | 入浴方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022094192A JP2023180678A (ja) | 2022-06-10 | 2022-06-10 | 入浴方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023180678A JP2023180678A (ja) | 2023-12-21 |
| JP2023180678A5 true JP2023180678A5 (https=) | 2025-03-26 |
Family
ID=89306913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022094192A Pending JP2023180678A (ja) | 2022-06-10 | 2022-06-10 | 入浴方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2023180678A (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6684251B2 (ja) * | 2017-04-06 | 2020-04-22 | 株式会社ホットアルバム炭酸泉タブレット | シャワー浴兼用の入浴用錠剤の製造方法及びシャワー浴兼用の入浴用錠剤 |
| JP6816066B2 (ja) * | 2018-06-28 | 2021-01-20 | 株式会社ホットアルバム炭酸泉タブレット | 足湯温まり方法及び足湯温まりセット |
-
2022
- 2022-06-10 JP JP2022094192A patent/JP2023180678A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6492142B2 (ja) | 足湯入浴時の温まり方法及び足湯入浴時の温まり持続用固形浴剤 | |
| JP6525945B2 (ja) | 錠剤の製造方法及び錠剤 | |
| JP5734457B2 (ja) | 入浴剤、皮膚外用剤、水の還元処理剤、還元水の製造方法、還元水及び対象物の還元処理方法 | |
| JP6684251B2 (ja) | シャワー浴兼用の入浴用錠剤の製造方法及びシャワー浴兼用の入浴用錠剤 | |
| JP2023180678A5 (https=) | ||
| JP5588490B2 (ja) | 錠剤の製造方法及び錠剤 | |
| JP6804242B2 (ja) | 頭髪毛根汚れ洗浄用固形洗浄剤及び頭髪毛根汚れ洗浄法 | |
| JP2023180678A (ja) | 入浴方法 | |
| JP2025035566A (ja) | 職業性ストレスの改善方法 | |
| JP2025009696A (ja) | 睡眠準備のための入浴方法 | |
| JP6744890B2 (ja) | マイクロバブル混合水の製造方法及び製造器 | |
| JP2025119151A (ja) | 重炭酸入浴剤及びその製造方法 | |
| JPH01238520A (ja) | 入浴剤 | |
| JP2025014976A (ja) | 重炭酸入浴剤及びその製造方法 | |
| US20230240978A1 (en) | Systems and methods for producing a nitric oxide bath and methods of use | |
| US20230022404A1 (en) | Systems and methods for producing a nitric oxide bath and methods of use | |
| JP2025079365A (ja) | 重炭酸入浴剤及びその製造方法 | |
| JPH0545567B2 (https=) | ||
| JPS6178717A (ja) | 発泡性浴用剤 | |
| JPS6277312A (ja) | 発泡性入浴剤 | |
| JP2023144304A (ja) | 炭酸マイクロバブル混合水を用いた入浴方法 | |
| JPS60185710A (ja) | 弱酸性入浴剤 | |
| JP2025074469A (ja) | 炭酸マイクロバブル混合水を用いた入浴方法 | |
| JP2025113795A (ja) | 入浴剤及び入浴剤の製造方法 | |
| JP2024085007A (ja) | 炭酸ファインバブル混合水を用いた入浴方法及び炭酸ファインバブルシャワー装置 |